Zealand Pharma increases share capital

December 13, 2016 Off By Dino Mustafić

Zealand Pharma has on Monday increased its share capital with nominal DKK 13,999 divided into 13,999 new shares with a nominal value of DKK 1 each.

The increase is a consequence of the exercise of warrants granted under one of Zealand’s employee warrant programs. Employee warrant programs are part of Zealand’s incentive scheme, and each warrant gives the owner the right to subscribe for one new Zealand share at a pre-specified price, the exercise price, in specific pre-defined time periods before expiration.

The exercise price is DKK 77 and the total proceeds to Zealand from the capital increase amounts to DKK 1,077,923.

The new shares give rights to dividend and other rights from the time of the warrant holder’s exercise notice. Each new share carries one vote at Zealand’s general meetings. Zealand only has one class of shares.

The new shares will be listed on Nasdaq Copenhagen after registration of the capital increase with the Danish Business Authority. Following registration of the new shares, the share capital of Zealand will be nominal DKK 26,142,365 divided into 26,142,365 shares with a nominal value of DKK 1 each.

The amendment of Zealand’s Articles of Association entailed by the share capital increase has today been registered with the Danish Business Authority.